Skip to main content

Main menu

  • Home
  • COVID-19
    • Podcasts
    • Articles
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Podcasts
    • Articles
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

What about bioavailability of oral curcumin?

Lora L. Aller
CMAJ April 15, 2019 191 (15) E427; DOI: https://doi.org/10.1503/cmaj.71708
Lora L. Aller
Retired physician, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

There seems to be a fundamental error in the research by Garg and colleagues.1

Both turmeric and curcumin have extremely poor oral bioavailability.2 Extensive research has been published on the oral availability of curcumin. There have been efforts to develop self-nanoemulsifying drug delivery systems and to combine the molecule with lipid carriers to improve bioavailability of curcumin.3

On a cultural level, Ayurvedic practitioners and Indian households have historically used turmeric (curcumin) in combination with fat (i.e., coconut oil — homestyle lipid complexes!), and black pepper (which vasodilates the gastric mucosa, enhancing absorption) with ginger, cinnamon and cardamom (similar effects). A quick check on the ingredients in Blume turmeric lattes as well as the “immune enhancer” tea at my local Iranian pharmacy reveals all these ingredients to be present in combination. There may be cultural wisdoms pertaining to these combinations that the authors did not investigate.

One expects rigorous scientific methods to be applied to a study of this size. In reviewing the methods, I found no mention or discussion of oral bioavailability, yet the curcumin “drug” was administered orally. To illustrate, one would not expect orally administered neomycin to treat any condition systemically as it is not orally absorbed. Much time, energy and funding were spent on this study. How could such a basic background question not be addressed? Would not one do a literature search to learn all one could? Would not one be curious as to the topic of oral bioavailability since the study participants were taking curcumin orally?

Root causes for this apparent oversight may include unfamiliarity with the entity curcumin and a bias against “natural health products.” Another problem may be the inherent structural application of a single variable (curcumin) as opposed to a multivariable study (i.e., turmeric with all its friends). If curcumin were a drug, its pharmacology would have been addressed.

The harm this type of neglect does is much clearer in the linked editorial.4 I see it as subtly shaming a basic cultural practice that uses turmeric (along with its complementary fats and spices) daily as well as the earnest reaching for health of many of our patients and communities who are exposed to these cultural practices in their yoga studios, with friends and cross-cultural pollination, trips to India and so on.

Could anyone reading the editorial now order their turmeric latte (in which the active ingredients are undoubtedly better absorbed and active) without feeling a bit ridiculous or subtly shamed? Could any researcher now seriously ask for funding for studies regarding the potential of turmeric to help prevent Alzheimer disease, which we are increasingly learning has roots in inflammation?

We owe it to our profession and community to practice rigorous scientific methods and to respect our subject, or we risk losing respect and alienating people. We also lose out on opening valuable new doors (e.g., prevention of familial colon cancer and mitigating the tolerance to morphine in patients with burns) and potential treatments for “fatty liver.” Let us work to mitigate unconscious bias in our work.5–9

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Garg AX,
    2. Devereaux PJ,
    3. Hill A,
    4. et al.
    Curcumin AAA AKI Investigators. Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial. CMAJ 2018;190: E1273–80.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Liu W,
    2. Zhai Y,
    3. Heng X,
    4. et al
    . Oral bioavailability of curcumin: problems and advancements. J Drug Target 2016;24:694–702.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Shukla M,
    2. Jaiswal S,
    3. Sharma A,
    4. et al
    . A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev Ind Pharm 2017;43:847–61.
    OpenUrl
  4. ↵
    1. Patrick K,
    2. Stanbrook MB
    . Take turmeric with a grain of salt. CMAJ 2018;190:E1270.
    OpenUrlFREE Full Text
  5. ↵
    1. Shen H,
    2. Hu X,
    3. Szymusiak M,
    4. et al
    . Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. Mol Pharm 2013;10:4546–51.
    OpenUrlCrossRef
    1. Cheppudira B,
    2. Fowler M,
    3. McGhee L,
    4. et al
    . Curcumin: a novel therapeutic for burn pain and wound healing. Expert Opin Investig Drugs 2013; 22:1295–303.
    OpenUrl
    1. Shen H,
    2. Hu X,
    3. Szymusiak M,
    4. et al
    . Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. Mol Pharm 2013;10:4546–51.
    OpenUrlCrossRef
    1. Cicero AFG,
    2. Colletti A,
    3. Bellentani S
    . Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. Nutrients 2018;10:E1153.
    OpenUrl
  6. ↵
    1. Cruz-Correa M,
    2. Shoskes DA,
    3. Sanchez P,
    4. et al
    . Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006;4:1035–8.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (15)
CMAJ
Vol. 191, Issue 15
15 Apr 2019
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
What about bioavailability of oral curcumin?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
What about bioavailability of oral curcumin?
Lora L. Aller
CMAJ Apr 2019, 191 (15) E427; DOI: 10.1503/cmaj.71708

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
What about bioavailability of oral curcumin?
Lora L. Aller
CMAJ Apr 2019, 191 (15) E427; DOI: 10.1503/cmaj.71708
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial
  • PubMed
  • Google Scholar

Cited By...

  • Bioavailability of oral curcumin
  • Google Scholar

More in this TOC Section

  • Intrapartum ultrasonography may improve operative vaginal delivery outcomes in Canada
  • Low-dose ketamine in the prehospital setting
  • Rethinking the idea of scientific discovery
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire